Freeline Therapeutics, a company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, announced the pricing of its initial public offering in the United States. Freeline Nasdaq IPO is UCL Technology Fund's 3rd IPO since its inception in 2016. 

Read more

Andrew Elder, Deputy Managing Partner AlbionVC discusses why alternative assets such as venture capital are a good home in a post pandemic world. 

Read more

Bramble Energy, a UCL Technology Fund portfolio spin-out, is the world’s most scalable hydrogen fuel cell company has raised a £5m Series A round from a combination of new and existing investors. 

 

Read more

UCL Technology Fund announces first close of £100m fund 2. Fund 2 follows the successes of the first fund and is committed to bring UCL’s academic research in life, computer and physical sciences to commercial reality.

Read more

Humanloop, a game changing UCL spinout, has attracted investment from UCL’s Technology Fund to enable AI systems to query human experts on only the most valuable data and learn much faster.

Read more

 

UCLTF Investment Directors, David Grimm and Simon Goldman discuss the impact of Covid-19 on university ventures. 

Read more

Jay Wilson, AlbionVC Investment Manager talks to Innovate Finance about fintech investment activity in the first half of 2020. 

Read more

Robert Whitby-Smith, AlbionVC partner chats with Computer Weekly about the importance of resilience for start-ups during the post covid-19 recession. 

Read more